Senior Director - Toxicology, CDDS @ Certara | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
External
0
Senior Director - Toxicology, CDDS jobs in United States
Be an early applicantLess than 25 applicants
company-logo

Certara · 1 day ago

Senior Director - Toxicology, CDDS

ftfMaximize your interview chances
BiotechnologyHealth Care
check
Growth Opportunities

Insider Connection @Certara

Discover valuable connections within the company who might provide insights and potential referrals.
Get 3x more responses when you reach out via email instead of LinkedIn.

Responsibilities

Contribute to due diligence and gap analysis of nonclinical data packages.
Design programs to support INDs, NDA/BLAs and post-registration studies.
Outline studies and in partnership with clients, identify CROs to run these studies; manage the data/information analysis with our client to draft reports and finalize with client.
Prepare content of regulatory documents for filing.
Design investigative programs to address toxicology findings/issues/circumstances to determine human relevance.
Represent client to regulatory authorities (as needed/requested).
Advise clients on prioritization of their portfolio.
Serve on cross-functional drug development teams as toxicology lead.
Provide toxicology overview of full portfolio with potential investors to assist clients in obtaining funding.
May manage a limited number of direct reports.
Influencing the disciplines of pharmacology and toxicology in the context of drug development.

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

PharmacologyDrug Development ExperienceRegulatory Agency InteractionRegulatory Submission AuthoringCross-Functional Team LeadershipBoard CertificationTK/PK Data AnalysisGLPNon-GLP StudiesTherapeutic Area KnowledgeSafety Margin GenerationClient ManagementProject ManagementMicrosoft WordMicrosoft PowerPoint

Required

PhD in quantitative Pharmacology or Toxicology, or related field.
At least 8-10 years post doctorate experience in a drug development company, CRO, consulting organization, or FDA (R&D, nonclinical drug development).
Experience in the design and outsourcing of GLP and non-GLP toxicology and safety pharmacology studies.
Drug development experience across multiple therapeutic areas, such as oncology, CNS, inflammation, autoimmunity, metabolic disease, or cardiovascular, with small molecules and biologics.
Experienced in the generation of safety margins based on nonclinical toxicity findings and target clinical exposure data.
Experience authoring the relevant nonclinical sections of IND’s, NDA/BLA’s, and other regulatory submission documents (SPA, pre-IND/Type B/Type C meeting briefing documents etc.
Ability to lead and work in cross functional project teams.
Demonstrated experience leading and managing projects.
Has served as a leader on teams and strongly demonstrated ability to work and excel in team collaboration.
Excellent written, verbal, and inter-personal communication skills.
Possess a strong focus on influencing at high levels, innovation, and customer centricity.
Strong initiative, self-motivation, and coordination with other team members.
Strong client and alliance management skills.
Ability to work across functions to implement company initiatives.
Proficient in Microsoft Word and Power Point.

Preferred

Pertinent Board Certification desirable.
Knowledge or experience with TK/PK data analysis and summary, with strong quantitative skills is preferred, but not required.
Experience in addressing comments/questions from Global regulatory agencies is desired, ideally from FDA, EMEA, PDMA and Health Canada.
Experience with development of pediatric, orphan, and/or ultra-orphan products is a plus.

Company

Certara

twittertwittertwitter
company-logo
Certara is a pharmaceutical company that accelerates medicines with biosimulation software and technology.

Funding

Current Stage
Public Company
Total Funding
$838.5M
Key Investors
U.S. Food and Drug AdministrationArsenal Capital PartnersMubadala
2023-08-29Grant· Undisclosed
2022-11-07Post Ipo Secondary· $449M
2021-09-20Grant· Undisclosed

Leadership Team

leader-logo
William Feehery
CEO
linkedin
leader-logo
Darrell Nix
Vice President, Global Head of Early Development Services
linkedin
Company data provided by crunchbase
logo

Orion

Your AI Copilot